ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT

Pts with acute coronary syndrome (ACS) vary in their risk for recurrent CV events. Ezetimibe (EZ) is safe and effective for 2° prevention with an overall 10% relative reduction in CV death, myocardial infarction or ischemic stroke (CVD/MI/iCVA). Risk assessment may be useful to identify pts who